Literature DB >> 19926147

HHV-6 infection of tonsils and adenoids in children with hypertrophy and upper airway recurrent infections.

Manola Comar1, Domenico Grasso, Gianna dal Molin, Elisabetta Zocconi, Cesare Campello.   

Abstract

OBJECTIVE: Human herpes virus 6 (HHV-6), the agent of a self-limiting exanthematic disease in childhood, persists in a silent state in the secondary lymphoid organs and the reactivation is characterized by HHV-6-induced inflammatory cytokines. This study investigates the possible etiological role of HHV-6 in children affected by tonsil and adenoid hypertrophy.
METHODS: 55 tonsils, 80 adenoids fresh tissues and 74 blood samples were collected from 80 children (mean age 4.8 years, 43.5% female) undergoing elective tonsillectomy and/or adenoidectomy for tissue hypertrophy. Moreover, patients with <5 years old documented upper airway recurrent infections not related to relapsing of acute tonsillitis. Specific IgG antibodies and virus detection (by PCR, variant A/B enzymatic genotyping and real-time PCR) were performed.
RESULTS: In our series, HHV-6 seroprevalence was tested at 50%. HHV-6 variant B was the unique strain finding in 25% of adenoids, in 12.7% of tonsils and in 4% of peripheral blood mononuclear cells (PBMCs). HHV-6-B was prevalent in tonsils of children affected by upper airway infections (17.8% vs 7.4%) while the adenoids represented the more frequent reservoir (30.7% vs 19.5%) in patients with hypertrophy. HHV-6 viral load was low, ranging from 80 to 600 copies/10(6) cells suggesting a latent/persistent phase of infection.
CONCLUSION: These results reinforce the role of the secondary lymphoid organs as an important reservoir for HHV-6B. Nevertheless, infection of lymphoid cells, sustained by a low level of replication, could be sufficient to increase the local injury through an autologous mechanism of inflammation. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926147     DOI: 10.1016/j.ijporl.2009.10.008

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  7 in total

1.  Human herpesvirus-6 entry into the central nervous system through the olfactory pathway.

Authors:  Erin Harberts; Karen Yao; Jillian E Wohler; Dragan Maric; Joan Ohayon; Robert Henkin; Steven Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 2.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

3.  Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis.

Authors:  Varpu Elenius; Maria Saarinen; Emilia Mikola; Oscar Palomares; Matti Waris; Riitta Turunen; Tuomo Puhakka; Lotta Ivaska; Beate Rückert; Alar Aab; Tero Vahlberg; Tytti Vuorinen; Tobias Allander; Carlos A Camargo; Mübeccel Akdis; Cezmi A Akdis; Tuomas Jartti
Journal:  Clin Transl Allergy       Date:  2018-05-22       Impact factor: 5.871

Review 4.  Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease?

Authors:  Afsar R Naqvi; Jennifer Shango; Alexandra Seal; Deepak Shukla; Salvador Nares
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

5.  The ubiquity of asymptomatic respiratory viral infections in the tonsils and adenoids of children and their impact on airway obstruction.

Authors:  Howard Faden; Vincent Callanan; Michael Pizzuto; Mark Nagy; Mark Wilby; Daryl Lamson; Brian Wrotniak; Stefan Juretschko; Kirsten St George
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2016-09-14       Impact factor: 1.675

6.  Intratonsillar detection of 27 distinct viruses: A cross-sectional study.

Authors:  Antti Silvoniemi; Emilia Mikola; Lotta Ivaska; Marja Jeskanen; Eliisa Löyttyniemi; Tuomo Puhakka; Tytti Vuorinen; Tuomas Jartti
Journal:  J Med Virol       Date:  2020-06-30       Impact factor: 2.327

7.  Herpesvirus infections in adenoids in patients with chronic adenotonsillar disease.

Authors:  Lotta E Ivaska; Antti Silvoniemi; Emilia Mikola; Tuomo Puhakka; Matti Waris; Tytti Vuorinen; Tuomas Jartti
Journal:  J Med Virol       Date:  2022-05-11       Impact factor: 20.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.